Presentation by Laura Medford Davis for the Third Annual Policy Prescriptions® Symposium
Laura Medford-Davis is a Robert Wood Johnson clinical scholar at University of Pennsylvania and a practicing emergency physician.
The symposium is designed for clinicians, healthcare workers, and healthcare executives interested in exploring the major themes that will emerge in health policy throughout the year. This year, the symposium will emphasize value in healthcare, health information technology, gun violence, insurance choices, the Affordable Care Act, and the viewpoints of the Presidential candidates on health care.
Ms. Hall is the former Vice President of Operations for Carena, a health care delivery company. Prior to joining Carena, Hall spent nearly 18 years with the Microsoft Corporation.
Oncology Care Model (OCM) are willing to take on two-sided riskJessica Parker
Oncology practitioners in CMS’s Oncology care model (OCM) are willing to take on two-sided risk, according to the Community Oncology Alliance (COA) survey.
HCC Coding Services: Achieve Accurate HCC Risk Adjustment CodingJessica Parker
CMS uses HCC to compensate Medicare Advantage plans established on the health of their members. It compensates accurately for the anticipated cost expenditures of the patients by adjusting those payments based on demographic information as well as patient as their health status.
Program Manager, Gastroenterologist at Associates in Gastroenterology in Rockville Maryland & the American College of Gastroenterology (ACG) Governor for Maryland
A presentation of information about transparency in healthcare reform. States are currently pursuing ways to make pricing information available to people before they even need it.
Ms. Hall is the former Vice President of Operations for Carena, a health care delivery company. Prior to joining Carena, Hall spent nearly 18 years with the Microsoft Corporation.
Oncology Care Model (OCM) are willing to take on two-sided riskJessica Parker
Oncology practitioners in CMS’s Oncology care model (OCM) are willing to take on two-sided risk, according to the Community Oncology Alliance (COA) survey.
HCC Coding Services: Achieve Accurate HCC Risk Adjustment CodingJessica Parker
CMS uses HCC to compensate Medicare Advantage plans established on the health of their members. It compensates accurately for the anticipated cost expenditures of the patients by adjusting those payments based on demographic information as well as patient as their health status.
Program Manager, Gastroenterologist at Associates in Gastroenterology in Rockville Maryland & the American College of Gastroenterology (ACG) Governor for Maryland
A presentation of information about transparency in healthcare reform. States are currently pursuing ways to make pricing information available to people before they even need it.
Transitioning to Value Based Care: Tennessee Oncology, A Case StudyWes Chapman
Transitioning to value based care in medical oncology is a major strategic change in any medical practice. In this presentation to Grand Rounds at the Norris Cotton Cancer Center at Dartmouth, we look at the strategic and operational considerations of making such a transition effective.
Indiana just passed major colorectal cancer (CRC) policy this year. Join us to listen to their story and learn what worked well for CRC advocacy in Indiana!
January 23, 2017
The Fifth Annual Health Law Year in P/Review symposium featured leading experts discussing major developments during 2016 and what to watch out for in 2017. The discussion at this day-long event covered hot topics in such areas as health policy under the new administration, regulatory issues in clinical research, law at the end-of-life, patient rights and advocacy, pharmaceutical policy, reproductive health, and public health law.
The Fifth Annual Health Law Year in P/Review was sponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, Harvard Health Publications at Harvard Medical School, Health Affairs, the Hastings Center, the Program On Regulation, Therapeutics, And Law (PORTAL) in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital, and the Center for Bioethics at Harvard Medical School, with support from the Oswald DeN. Cammann Fund.
Learn more on our website: http://petrieflom.law.harvard.edu/events/details/5th-annual-health-law-year-in-p-review
January 23, 2017
The Fifth Annual Health Law Year in P/Review symposium featured leading experts discussing major developments during 2016 and what to watch out for in 2017. The discussion at this day-long event covered hot topics in such areas as health policy under the new administration, regulatory issues in clinical research, law at the end-of-life, patient rights and advocacy, pharmaceutical policy, reproductive health, and public health law.
The Fifth Annual Health Law Year in P/Review was sponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, Harvard Health Publications at Harvard Medical School, Health Affairs, the Hastings Center, the Program On Regulation, Therapeutics, And Law (PORTAL) in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital, and the Center for Bioethics at Harvard Medical School, with support from the Oswald DeN. Cammann Fund.
Learn more on our website: http://petrieflom.law.harvard.edu/events/details/5th-annual-health-law-year-in-p-review
Implementing a Population Health Model (Hon Pak)Ashleigh Kades
Speaker Presentation from U.S. News Healthcare of Tomorrow leadership summit, November 2-4, 2016 in Washington, DC. Find out more about this forum at www.usnewshot.com.
Health Datapalooza 2013: Transforming Benefits Design - Sherri ZinkHealth Data Consortium
Health Datapalooza IV: June 3rd-4th, 2013
Transforming Benefits Design and Delivery Through the Analysis and Exchange of Personal Health Data
Moderator:
Myrl Weinberg, Chief Executive Officer, National Health Council
Speakers:
Martha Wofford, Vice President / Head of Consumer Platform, Aetna
Sherri Zink, Vice President, Medical Informatics, BlueCross BlueShield of Tennessee
New products and services are making it easier for people to gather information about their health, as well as share this information with providers and other health care stakeholders. Learn how health plans are looking at the future of consumer engagement and how new emerging sources and types of health data are being used to prevent and manage disease more effectively.
This session is eligible for continuing education credit.
Compliance and Legal Risks in Laborist, Surgicalist, and Hospitalist Arrangem...MD Ranger, Inc.
Have you structured your hospital-based physician contracts to address all aspects of compliance?
Hospitalist agreements involve unique compliance and financial issues, particularly when global payments and advanced practice providers are involved. Risks include indirect compensation, billing and other compliance issues. This presentation will discuss compliance risks and provide guidance on how to structure compliant contracts and business arrangements.
Get your message across with Super Wide and UV Substrate Printing. Promote your development project and/or business with high quality, eye-catching signage, point of purchase materials and custom fabricated print solutions.
Transitioning to Value Based Care: Tennessee Oncology, A Case StudyWes Chapman
Transitioning to value based care in medical oncology is a major strategic change in any medical practice. In this presentation to Grand Rounds at the Norris Cotton Cancer Center at Dartmouth, we look at the strategic and operational considerations of making such a transition effective.
Indiana just passed major colorectal cancer (CRC) policy this year. Join us to listen to their story and learn what worked well for CRC advocacy in Indiana!
January 23, 2017
The Fifth Annual Health Law Year in P/Review symposium featured leading experts discussing major developments during 2016 and what to watch out for in 2017. The discussion at this day-long event covered hot topics in such areas as health policy under the new administration, regulatory issues in clinical research, law at the end-of-life, patient rights and advocacy, pharmaceutical policy, reproductive health, and public health law.
The Fifth Annual Health Law Year in P/Review was sponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, Harvard Health Publications at Harvard Medical School, Health Affairs, the Hastings Center, the Program On Regulation, Therapeutics, And Law (PORTAL) in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital, and the Center for Bioethics at Harvard Medical School, with support from the Oswald DeN. Cammann Fund.
Learn more on our website: http://petrieflom.law.harvard.edu/events/details/5th-annual-health-law-year-in-p-review
January 23, 2017
The Fifth Annual Health Law Year in P/Review symposium featured leading experts discussing major developments during 2016 and what to watch out for in 2017. The discussion at this day-long event covered hot topics in such areas as health policy under the new administration, regulatory issues in clinical research, law at the end-of-life, patient rights and advocacy, pharmaceutical policy, reproductive health, and public health law.
The Fifth Annual Health Law Year in P/Review was sponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, Harvard Health Publications at Harvard Medical School, Health Affairs, the Hastings Center, the Program On Regulation, Therapeutics, And Law (PORTAL) in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital, and the Center for Bioethics at Harvard Medical School, with support from the Oswald DeN. Cammann Fund.
Learn more on our website: http://petrieflom.law.harvard.edu/events/details/5th-annual-health-law-year-in-p-review
Implementing a Population Health Model (Hon Pak)Ashleigh Kades
Speaker Presentation from U.S. News Healthcare of Tomorrow leadership summit, November 2-4, 2016 in Washington, DC. Find out more about this forum at www.usnewshot.com.
Health Datapalooza 2013: Transforming Benefits Design - Sherri ZinkHealth Data Consortium
Health Datapalooza IV: June 3rd-4th, 2013
Transforming Benefits Design and Delivery Through the Analysis and Exchange of Personal Health Data
Moderator:
Myrl Weinberg, Chief Executive Officer, National Health Council
Speakers:
Martha Wofford, Vice President / Head of Consumer Platform, Aetna
Sherri Zink, Vice President, Medical Informatics, BlueCross BlueShield of Tennessee
New products and services are making it easier for people to gather information about their health, as well as share this information with providers and other health care stakeholders. Learn how health plans are looking at the future of consumer engagement and how new emerging sources and types of health data are being used to prevent and manage disease more effectively.
This session is eligible for continuing education credit.
Compliance and Legal Risks in Laborist, Surgicalist, and Hospitalist Arrangem...MD Ranger, Inc.
Have you structured your hospital-based physician contracts to address all aspects of compliance?
Hospitalist agreements involve unique compliance and financial issues, particularly when global payments and advanced practice providers are involved. Risks include indirect compensation, billing and other compliance issues. This presentation will discuss compliance risks and provide guidance on how to structure compliant contracts and business arrangements.
Get your message across with Super Wide and UV Substrate Printing. Promote your development project and/or business with high quality, eye-catching signage, point of purchase materials and custom fabricated print solutions.
Time for a Reality Check on Health InsuranceCedric Dark
Presentation by Elena Marks, JD, MPH for the Third Annual Policy Prescriptions® Symposium
Elena M. Marks is the president and chief executive officer of the Episcopal Health Foundation and a nonresident fellow in Health Policy at Rice University’s Baker Institute for Public Policy.
Marks previously served as the director of Health and Environmental Policy for the City of Houston. Prior to joining the mayor’s staff, Marks practiced trial and appellate law with major law firms, started and directed a successful legal placement firm, and developed strategic, long-range, and operating plans for service lines and system centers at a major health system.
The symposium is designed for clinicians, healthcare workers, and healthcare executives interested in exploring the major themes that will emerge in health policy throughout the year. This year, the symposium will emphasize value in healthcare, health information technology, gun violence, insurance choices, the Affordable Care Act, and the viewpoints of the Presidential candidates on health care.
Tala ant egg oil is hair reducing products.This protein does not hurt your body functions or your skin.Tala has been the most useful product for men and women.With continuous use of this product,adult people will solve their hairs problem.
The Future of the American Healthcare Delivery System in an Era of ChangePYA, P.C.
PYA Principal Dr. Kent Bottles, who is also PYA Analytics' Chief Medical Officer, gave the keynote address, "The Future of the American Healthcare Delivery System in an Era of Change at the Healthcare Business Intelligence Summit," September 19, 2013, in Minneapolis. Dr. Bottles discussed four key trends affecting the American healthcare delivery system: the Affordable Care Act (“ACA”), the digital revolution, big data, and social media. He examined how these trends together affect the way hospitals, providers, payers, employers, and government agencies adapt to the changing healthcare environment.
How to Engage Physicians in Best Practices to Respond to Healthcare Transform...PYA, P.C.
PYA Principal Kent Bottles, MD, spoke about physician engagement when it comes to value payment models during “How to Engage Physicians in Best Practices to Respond to Healthcare Transformation” at the Georgia Society of Certified Public Accountants’ (GSCPA) 2016 Healthcare Conference, February 11, 2016. Dr. Bottles discussed the difficulty of weaning physicians from fee-for-service payment models and the often-unappreciated reasoning behind the shift to value-based payment models. He also highlighted MACRA, MIPS, patient satisfaction surveys, Physician Compare, and the ProPublica Surgeon Scorecard.
Healthcare Consumerism and Cost: Dispelling the Myth of Price TransparencyHealth Catalyst
The world of healthcare costs is confusing and messy for both patients and providers. Many providers don’t fully understand their costs and therefore struggle to meet the increasing pressure for greater price transparency for consumers. With price transparency rules finalized and implementation looming, many providers are racing against the clock to adapt business practices to meet regulations and communicate the implications to consumers. And each organization’s financial health depends on transparency, as uncertainty about costs keeps many patients from seeking care.
Deb Gordon, seasoned healthcare executive and author of the book, “The Health Care Consumer’s Manifesto: How to Get the Most for Your Money,” and Pat Rocap, Director of Cost Management Services at Health Catalyst, examine the relationship between cost and pricing as the path to transparency for consumers. Deb and Pat provide expert analysis and practical advice to help you become a savvier provider and consumer when it comes to healthcare pricing and spending.
- The implications of federal price transparency regulations.
- The connection between healthcare costing and pricing.
- How to start your organization’s journey to understand costs and why it matters.
- Why price transparency is important to both patients and providers.
Evolving Approaches to Measuring the Value of New Health Technologies in the USOffice of Health Economics
At this OHE Lunchtime Seminar, Dr Steven Pearson of the ICER organisation in the US discussed current US approaches to defining "value," compared these to NICE and discussed what changes may occur in the future.
At the 2014 HFMA National Institute, PYA Principal and Chief Medical Officer of PYA Analytics, Kent Bottles, MD, spoke about the strategies that hospitals and health systems are using to decrease per-capita cost, while increasing quality. In the session, “Achieving Rapid Cost Reduction and Revenue Improvement by Engaging Clinicians and Administrators,” Bottles offered tactics for engagement.
Kathryn Phillips, PhD presents "Value of Personalized Health Care: What is it? How to measure it? Why Care" at the 2009 Personalized Health Care National Conference at Ohio State University.
Dr. Phillips is Professor of Health Economics and Health Services Research and director/founder of the Center for Translational and Policy Research on Personalized Medicine at the University of California San Francisco.
The Evolution of Consumer Driven Health PlansPaladina Health
The Evolution of Consumer Driven Health Plans White Paper will prepare you for the following regarding the shift to true healthcare consumerism:
- What types of employer-sponsored health plans exist and what employers should consider
- The impact of consumer driven health plans (CDHPs) and high deductible health plans (HDHPs) in controlling healthcare costs
- What models challenge the fee-for-service delivery system and why employers need to explore them
Medical Bill Challenge: A Bill You Can UnderstandLiz Griffith
Launched at Mad*Pow's annual HXR conference, The ‘A Bill You Can Understand’ design and innovation challenge demonstrates that ‘collaboration is the new innovation.’ Public and private players leveraged their respective platforms, expertise, and perspective to accelerate progress toward solving a key consumer pain point with our health care system.
Two challenge winners were selected from 84 submissions and were announced at the Health 2.0 conference on September 28, 2016. There were also 10 submissions who received an honorable mention. A big thanks goes out to all who were involved in the challenge.
This webinar shares lessons learned from the challenge from Mad*Pow's Paul Kahn.
Lesson Learned from "A Bill You Can Understand" Design Challenge - HXR 2016 -...Mad*Pow
Launched at Mad*Pow's annual HXR conference, The ‘A Bill You Can Understand’ design and innovation challenge demonstrates that ‘collaboration is the new innovation.’ Public and private players leveraged their respective platforms, expertise, and perspective to accelerate progress toward solving a key consumer pain point with our health care system.
Two challenge winners were selected from 84 submissions and were announced at the Health 2.0 conference on September 28, 2016. There were also 10 submissions who received an honorable mention. A big thanks goes out to all who were involved in the challenge.
This webinar shares lessons learned from the challenge from Mad*Pow's Paul Kahn.
Harness Your Clinical and Financial Data with an Enterprise Health Informat...Perficient, Inc.
The importance of Enterprise Health Information Exchange (EHIE) as a key way to empower your physicians and patients and demonstrate meaningful use of electronic health records:
- Present the business case for EHIE as an important architecture that matters to progressive health systems
- Take a look at some of the market-leading EHIE architectures and products
- Provide real exam...ples of organizations that are using EHIE to improve their operations
Employee Engagement: Your Tool for Tackling Heath Care CostsDigital Measures
Everyone is concerned about increasing health care costs. This interactive session will review the various triggers that drive health care and insurance costs and cover the major communication and engagement strategies that companies use to reduce their trend. Case studies to be discussed include wellness, employee engagement and communication, benefit plan design and consumerism. Successful benefit incentive programs that support communication programs and have a quantifiable return on investment will also be discussed.
Who Knew Health Care Could Be This Complicated?Cedric Dark
A talk I gave to the Spring Branch Democrats (Houston, TX) just as the "Skinny Repeal" was released to the public and hours before it's ultimate failure.
Presentation by Cedric Dark, MD, MPH & Rosalia Guerrero-Luera
for the Third Annual Policy Prescriptions® Symposium
Cedric Dark is the founder and executive editor at Policy Prescriptions® and an assistant professor at Baylor College of Medicine Section of Emergency Medicine
The symposium is designed for clinicians, healthcare workers, and healthcare executives interested in exploring the major themes that will emerge in health policy throughout the year. This year, the symposium will emphasize value in healthcare, health information technology, gun violence, insurance choices, the Affordable Care Act, and the viewpoints of the Presidential candidates on health care.
The Big Bang Theory: Evidence-Based Strategies to Reduce Gun ViolenceCedric Dark
Presentation by Bich-May Nguyen, MD, MPH for the Third Annual Policy Prescriptions® Symposium
Bich-May Nguyen is an assistant professor at Baylor College of Medicine, Department of Family Medicine
The symposium is designed for clinicians, healthcare workers, and healthcare executives interested in exploring the major themes that will emerge in health policy throughout the year. This year, the symposium will emphasize value in healthcare, health information technology, gun violence, insurance choices, the Affordable Care Act, and the viewpoints of the Presidential candidates on health care.
The Affordable Care Act: An Evidence-Based UpdateCedric Dark
Presentation by Seth Trueger, MD, MPH for the Third Annual Policy Prescriptions® Symposium
Seth Trueger is an assistant professor at the University of Chicago, Section of Emergency Medicine.
The symposium is designed for clinicians, healthcare workers, and healthcare executives interested in exploring the major themes that will emerge in health policy throughout the year. This year, the symposium will emphasize value in healthcare, health information technology, gun violence, insurance choices, the Affordable Care Act, and the viewpoints of the Presidential candidates on health care.
Presentation by Megan Douglas, JD for the Third Annual Policy Prescriptions® Symposium
She is the associate director of Health Information Technology Policy in the National Center for Primary Care at Morehouse School of Medicine.
The symposium is designed for clinicians, healthcare workers, and healthcare executives interested in exploring the major themes that will emerge in health policy throughout the year. This year, the symposium will emphasize value in healthcare, health information technology, gun violence, insurance choices, the Affordable Care Act, and the viewpoints of the Presidential candidates on health care.
Competition or Collaboration - 2015 Policy Prescriptions® SymposiumCedric Dark
The symposium is designed for clinicians – physicians, nurses, nurse practitioners, physician assistants, and students – and healthcare executives interested in expanding their scope of knowledge about currently popular health policy topics.
How to Cover the Last...Millions - 2015 Policy Prescriptions® SymposiumCedric Dark
The symposium is designed for clinicians – physicians, nurses, nurse practitioners, physician assistants, and students – and healthcare executives interested in expanding their scope of knowledge about currently popular health policy topics.
Leveraging Telemedicine to Improve Health - 2015 Policy Prescriptions Symposium®Cedric Dark
The symposium is designed for clinicians – physicians, nurses, nurse practitioners, physician assistants, and students – and healthcare executives interested in expanding their scope of knowledge about currently popular health policy topics.
The Near Future of Healthcare Delivery - 2015 Policy Prescriptions® SymposiumCedric Dark
The symposium is designed for clinicians – physicians, nurses, nurse practitioners, physician assistants, and students – and healthcare executives interested in expanding their scope of knowledge about currently popular health policy topics.
ACA: Evidence-Based Update - 2015 Policy Prescriptions® SymposiumCedric Dark
The symposium is designed for clinicians – physicians, nurses, nurse practitioners, physician assistants, and students – and healthcare executives interested in expanding their scope of knowledge about currently popular health policy topics.
This presentation is by Dr. Seth Trueger. Dr. Trueger is an emergency physician in Chicago whose interests include social media for health professions, payment and delivery reform, crowding, airway, and resuscitation. He is the Assistant Social Media Editor for Annals of Emergency Medicine. He worked as a health fellow / legislative aide in the office of Congressman John Dingell (D-MI) from 9/2013-3/2014 (while still seeing patients, of course). And since January 1, 2013, has served as the Social Media (Twitter) Editor for Emergency Physicians Monthly. You can follow him on Twitter @MDAware or online at MDAware[dot]org.
Medical Malpractice: Don't Believe the Hype - 2015 Policy Prescriptions® Symp...Cedric Dark
The symposium is designed for clinicians – physicians, nurses, nurse practitioners, physician assistants, and students – and healthcare executives interested in expanding their scope of knowledge about currently popular health policy topics.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
2. The Following Presenters Have Disclosed Relevant Financial Relationships:
Cedric Dark, MD MPH FAAEM FACEP
Community Health Choice, Event Sponsorship; Schumacher Clinical Partners, Event Sponsorship
Seth Trueger, MD MPH
Emergency Physicians Monthly, Employee, Salary
The Following Presenters Have Disclosed No Financial Relationships:
Megan Douglas, JD
Elena M. Marks, JD MPH
Laura Medford-Davis, MD
Bich-May Nguyen, MD MPH
The Following Planners Have Disclosed Relevant Financial Relationships:
Cedric Dark, MD MPH FAAEM FACEP
Community Health Choice, Event Sponsorship; Schumacher Clinical Partners,
Event Sponsorship
The Following Planning Committee Members and Staff Have Disclosed No
Relevant Financial Relationships:
Emily DeVillers, CAE
Kay Whalen, MBA CAE
Janet Wilson, CAE
I have nothing to disclose.
18. Evidence is Mixed
• Patients informed of MRI costs and options pre-MRI
– 18% cost reduction
• Employer offered a price transparency tool
– Tool used before 6% of claims
– Those who used it were more expensive pre-tool
– 14% cost reduction
• Employer offered a price transparency tool and
another did not
– 10% of employees used it
– $59 price increase
20. Best Practices for Transparency
• Estimates tailored to the patient, provider, and
insurance plan
– Specific prices, not averages, medians, or ranges
• Quality information
• Real-time availability
21. Problems with Current Transparency Tools
• Episodes not clearly defined
– CPT codes
• Limited number of services included
• Not linked to quality
• Hard to keep up-to-date with inflation and contract
changes
• Skewed by overutilization (and underutilization)
23. Barriers to Transparency
• Non-disclosure agreements
• Price protected under Trade Secrets
• Most-Favored Nation clauses
• Anti-tiering clauses
24. HCi3 – State Report Card on Price
Transparency Laws
25. 28 States Have Price Transparency Laws
• Allow states to collect information
• Require hospitals to disclose to the state
• Average charges or chargemasters
• Price disclosure upon request
26. States with Stronger Laws
• MA & WA: Insurance companies → Patients
• KS: Insurance companies → Providers
• CO: public all payer claims database
– Hospitals → Patients (average cost)
34. Dartmouth Atlas of Health Care
$219,591.42
$141,546.80
$119,526.19
$119,299.22
$117,916.27
$102,629.93
$99,255.48
$82,744.36
$77,528.25
$68,835.92
$42,120.81
$0.00
$50,000.00
$100,000.00
$150,000.00
$200,000.00
$250,000.00 1. Los Angeles Community Hospital
37. MD Anderson Cancer Center
97. Brigham & Womens
98. Hospital of the University of Pennsylvania
113. Park Plaza Hospital
266. St Lukes Episcopal
328. Memorial Hermann Medical Center
841. Cleveland Clinic
1093. Scott & White Memorial
1687. Geisinger
2074. Brookings (South Dakota)
42. Key Takeaways
• We have a lack of transparency in the USA
• Evidence on the benefits of transparency is mixed
• The majority of states have “policies” but most are
weak and ineffective
• Resources for cost comparisons exist, but most
provide averages or insurer-specific information